Astec Lifesciences Ltd Quarterly Results

Gross Sales

119.53

93.86

98.55

69.37

153.75

Excise Duty

0

0

0

0

0

Net Sales

119.53

93.86

98.55

69.37

153.75

Other Operating Income

0

0

0

0

0

Other Income

0.79

1.91

2

0.92

2.05

Total Income

120.32

95.77

100.54

70.3

155.8

Total Expenditure

114

99.6

118.28

115.63

141.04

PBIDT

6.32

-3.83

-17.74

-45.33

14.76

Interest

10.4

9.92

9.33

7.04

6.67

PBDT

-4.08

-13.75

-27.07

-52.37

8.08

Depreciation

11.58

11.4

11.47

9.27

9.01

Minority Interest Before NP

0

0

0

0

0

Tax

0.01

0.01

0.01

0.01

0.01

Deferred Tax

0.4

15.21

0

-21.93

0.03

Reported Profit After Tax

-16.08

-40.37

-38.55

-39.72

-0.96

Minority Interest After NP

0.01

0.01

0.01

0.01

0.01

Net Profit after Minority Interest

-16.09

-40.38

-38.56

-39.72

-0.97

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-16.09

-40.38

-38.56

-39.72

-0.97

EPS (Unit Curr.)

-8.2

-20.59

-19.66

-20.26

-0.5

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

19.61

19.61

19.61

19.61

19.61

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

5.28

-4.08

-18

-65.34

9.6

PBDTM(%)

-3.41

-14.64

-27.46

-75.49

5.25

PATM(%)

-13.45

-43.01

-39.11

-57.25

-0.62